您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Foxy-5(TFA)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Foxy-5(TFA)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Foxy-5(TFA)图片
规格:98%
分子量:808.8
包装与价格:
包装价格(元)
1mg电议
5mg电议
10mg电议
50mg电议

产品介绍
Foxy-5 是一种缺乏硫酸肝素结合域 WNT5A 模拟肽,具有抗转移作用。Foxy-5 在不影响 β-连环蛋白激活的情况下触发细胞溶质游离钙信号传导,并损害上皮癌细胞的迁移和侵袭。
货号:ajcx13908
CAS:N/A
分子式:C28H43F3N6O14S2
分子量:808.8
溶解度:H2O: 20 mg/mL (24.73 mM)
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Foxy-5 is a WNT5A mimicking peptide with anti-metastatic effect, which lacks a heparan sulfate-binding domain. Foxy-5 triggers cytosolic free calcium signaling without affecting β-catenin activation and it impairs the migration and invasion of epithelial cancer cells[1][2][3].


[1]. Canesin G, et al. Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model. PLoS One. 2017 Sep 8;12(9):e0184418. [2]. SÄfholm A, et al. The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility. Clin Cancer Res. 2008 Oct 15;14(20):6556-63. [3]. Kelsey R. Prostate cancer: Foxy-5 in prostate cancer model. Nat Rev Urol. 2017 Nov;14(11):638.